News by topic

Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Changing treatment news

Show

From To
India: SC forces govt to agree to second-line ART to all AIDS patients

NEW DELHI: The Centre on Friday tried everything -- from huge costs to irrational treatment by private hospitals -- to express reservations about extending second-line treatment to all HIV positive patients, but the Supreme Court used the right to life argument to counter them. The government had said it was willing to extend second-line treatment costing Rs 28,500 each to all patients except ...

Published
11 December 2010
From
Times of India
Side-effects
Switching from efavirenz to etravirine improves mood and sleep

Switching from efavirenz to etravirine is associated with significant improvements in central nervous system side-effects, UK investigators report in the online edition of AIDS. Patients were less likely

Published
07 December 2010
By
Michael Carter
Changing treatment
ZAMBIA: Ephraim Banda, The third-line drugs we don't have

LUSAKA, 23 November 2010 (PLUSNEWS) - Before Zambia's public health sector started providing free antiretroviral drugs (ARVs) to people living with HIV, Ephraim Banda bought his own medication. But his supply was often interrupted and the available drugs changed frequently and he is now one of a growing number of HIV-positive Zambians who have developed resistance to both first- and second-line ARV drug regimens.

Published
23 November 2010
From
IRIN Plus News
No evidence that patients taking long-term efavirenz want to switch to etravirine

Patients who are on long-term efavirenz therapy do not prefer etravirine after switching to this drug, Swiss investigators report in the online edition of AIDS. Switching to etravirine

Published
18 November 2010
By
Michael Carter
India
All HIV patients to get second-line treatment free

All HIV patients put on antiretroviral therapy before 2004 but who became resistant to those drugs will now receive the life saving second line treatment free of cost from the National AIDS Control Organisation (NACO).

Published
13 November 2010
From
Times of India
New and experimental HIV treatments
Protease inhibitor monotherapy in African setting results in viral load, but not CD4, failure in the short term

A study of protease inhibitor monotherapy in Africa has found that 25% fewer patients on monotherapy achieved an undetectable viral load than those on standard combination therapy.

Published
10 November 2010
By
Gus Cairns
Treatment-experienced people
Darunavir working well for highly treatment-experienced patients in Switzerland

Outcomes for treatment-experienced patients receiving 'salvage therapy' that includes the protease inhibitor darunavir (Prezista) are equal to, or even better, than those seen in clinical trials,

Published
25 October 2010
By
Michael Carter
Bone problems
Switch from efavirenz or AZT associated with improvement in vitamin D levels

Switching antiretroviral treatment from efavirenz or AZT was associated with an improvment in vitamin D levels, investigators report in the online edition of AIDS Research

Published
20 October 2010
By
Michael Carter
Changing treatment
Adding drugs to already successful HIV treatment doesn't reduce viral load further

Intensifying effective HIV therapy with the addition of an extra drug that crosses the blood-brain barrier does not reduce residual levels of viral replication in cerebrospinal fluids or

Published
15 October 2010
By
Michael Carter
Changing treatment
Targeted viral load tests in India prevent switches to second-line ARVs for one in four

Targeted viral load testing combined with clinical and immunological evaluation in cases of first-line antiretroviral treatment failure prevented unnecessary treatment switches in 25% of patients in a public

Published
13 October 2010
By
Carole Leach-Lemens
← Prev1...34567...21Next →

Filter by country